1. Food and Drug Administration. FDA approves first biosimilar product Zarxio [media release]. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm436648.htm . Accessed 20 Sep 2015.
2. Judgement by European Union Civil Service Tribunal on appointment procedure of EMA Executive Director, November 2014. Available at: http://www.raps.org/Regulatory-Focus/News/2014/11/14/20741/EMAs-Top-Drug-Regulator-Guido-Rasi-Forced-to-Step-Down/ . Accessed 22 Sep 2015.
3. Order of the Vice-President of the Court of 28 November 2013. European Medicines Agency (EMA) v AbbVie Inc. and AbbVie Ltd. Appeal—order for interim measures—Regulation (EC) No 1049/2001—documents held by the European Medicines Agency in the context of an application for authorisation to place a medicinal product on the market—decision to grant a third party access to the documents; Case C-389/13 P(R).
4. European Medicines Agency. Second stakeholder meeting on the implementation of the European Medicines Agency’s policy on publication of clinical data for human medicines. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2015/09/event_detail_001222.jsp&mid=WC0b01ac058004d5c3 . Accessed 28 Sep 2015.
5. Godlee F. Study 329. BMJ. 2015;351:h4973.